Clinical Trials Search Results
The results of your search are listed below. To view the details of a trial or study, click on the link. Or start a new search.
| Searched for: Ovarian Cancer | 4 results total |
A Phase II Trial of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) with Weekly Protein Bound Paclitaxel (Abraxane™) as Chemoimmunotherapy for Platinum-Resistant Epithelial Ovarian Cancer
Ron Swensen, MD
6168
Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-Line Therapy
Benjamin Greer, MD
GOG 0187
A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12, Monthly Cycles of Single Agent Paclitaxel or Xyotax (CT-2103) (IND # 70177), Versus No Treatment Until Documented Relapse in Women with Advanced Ovarian or Primary Peritoneal Cancer Who Achieve a Complete Clinical Response to Primary Platinum/Taxane Chemotherapy
Benjamin Greer, MD
GOG 0212
A Phase I Study Evaluating a Second Generation Antisense Oligonucleotide (OGX-427) that Inhibits Heat Shock Protein 27 (Hsp 27)
Evan Yu, MD
20070773
Search Options
OR
OR
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Please remember:
- Talk to your health care providers first before making decisions about your health care.
- Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.
Terms of Use and Privacy Policy
Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024 Seattle, WA 98109
©2009 Fred Hutchinson Cancer Research Center, a nonprofit organization.
Terms of Use & Privacy Policy.
